why choose us

First received: November 13, 2023

Clinical Trial: A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Prostatic Neoplasms

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Clinical Study to Investigate the Safety and Pharmacokinetics of MK-5684 in China Participants With Metastatic Castration-Resistant Prostate Cancer

Brief Summary: The primary objectives of this study are to evaluate the safety and tolerability of opevesostat in the treatment of male Chinese participants with metastatic castration-resistant prostate cancer (mCRPC) and to characterize the pharmacokinetic profile of opevesostat.There are no formal hypotheses to be tested in this study.

Read more